Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAssura Regulatory News (AGR)

Share Price Information for Assura (AGR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.10
Bid: 39.04
Ask: 39.20
Change: -0.34 (-0.86%)
Spread: 0.16 (0.41%)
Open: 39.16
High: 39.56
Low: 39.06
Prev. Close: 39.44
AGR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of Chief Financial Officer

4 Aug 2017 07:00

RNS Number : 0712N
Assura PLC
04 August 2017
 

 

4 August 2017

 

Assura plc

 

Appointment of Chief Financial Officer

 

Assura plc ("Assura" or the "Company"), the leading investor and developer of primary care properties, is pleased to announce the appointment of Jayne Cottam to the Board as Chief Financial Officer ("CFO"). Jayne is expected to join the Company before the end of October 2017. Jonathan Murphy has continued to fulfil the role of CFO since his appointment earlier this year as Chief Executive Officer ("CEO") and will do so until Jayne joins Assura.

Jayne, a CIMA qualified accountant, joins Assura from one of the UK's largest private national housing developers. She is currently the Finance Director for Operations, heading up the operational finance team across the group and providing financial and strategic support as a member of the board for each of the three operating regions. Jayne was previously Director of Finance for the Continental Europe Division of European Metal Recycling Limited, one of the worlds' largest metal recyclers, and before that held a number of other senior finance positions.

Jonathan Murphy, CEO of Assura, commented:

"I am delighted that Jayne Cottam will be joining Assura as Chief Financial Officer. Jayne brings a wealth of relevant experience and her financial expertise will prove extremely valuable as we continue to deliver shareholder value and pursue our strategy of investing to support the UK's primary healthcare infrastructure."

Commenting on her appointment, Jayne Cottam said:

"Assura has built a strong business with many opportunities for further growth in a still-developing sector. I am very excited to be joining the Company and look forward to working with Jonathan and the team in helping to support the NHS in providing them with the buildings they need today for the NHS of the future."

There are no further disclosures required pursuant to paragraph 9.6.13 of the Listing Rules.

 

- Ends -

 

 

For more information, please contact:

 

Assura plc

 

Tel: 01925 420660

Jonathan Murphy

 

Orla Ball

 

 

Finsbury

 

Tel: 0207 251 3801

Gordon Simpson

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 31 March 2017, Assura's property portfolio was valued at £1,345 million.

 

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGURPRUPMGCW
Date   Source Headline
22nd Jul 20145:29 pmRNSAnnual Information Update
22nd Jul 20144:57 pmRNSResult of AGM
1st Jul 201412:16 pmRNSTotal Voting Rights and Issued Share Capital
1st Jul 20149:24 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
23rd Jun 20145:15 pmRNSNotification of Major Interest in Shares
20th Jun 20143:34 pmRNSAnnual Report & Notice of AGM
13th Jun 20147:00 amRNSAcquisition of 28 medical centres for £107 million
10th Jun 20149:44 amRNSConfirmation of Quarterly Interim Dividend
23rd May 20147:00 amRNSPreliminary results for year ended 31 March 2014
2nd Apr 201411:42 amRNSConfirmation of Quarterly Interim Dividend
4th Mar 201412:00 pmRNSDirector/PDMR Shareholding
14th Feb 20147:00 amRNSInterim Management Statement
13th Feb 201411:58 amRNSNotification of Major Interest in Shares
11th Feb 20144:48 pmRNSNotification of Major Interest in Shares
29th Jan 20144:39 pmRNSNotification of Vesting of Share Award to PDMR
24th Jan 201410:17 amRNSDirector/PDMR Shareholding
24th Jan 20147:00 amRNSSale of LIFT Investments
2nd Jan 20144:15 pmRNSDirector/PDMR Shareholding
20th Dec 201310:46 amRNSConfirmation of Quarterly Interim Dividend
12th Dec 20131:17 pmRNSNotification of major interest in shares
11th Dec 20133:23 pmRNSNotification of major interest in shares
10th Dec 20133:45 pmRNSNotification of major interest in shares
9th Dec 20133:52 pmRNSNotification of major interest in shares
9th Dec 20133:01 pmRNSNotification of major interest in shares
3rd Dec 20134:22 pmRNSDirector/PDMR Shareholding
3rd Dec 201310:18 amRNSNotification of major interest in shares
27th Nov 20131:03 pmRNSDirector/PDMR Shareholding
27th Nov 20131:01 pmRNSDirector/PDMR Shareholding
26th Nov 20137:00 amRNSInterim Results 2013
25th Nov 20137:00 amRNSSale of LIFT Investments
5th Nov 20133:43 pmRNSDirector Declaration
5th Nov 20131:23 pmRNSNotification of Major Interests in Shares
14th Oct 20131:31 pmRNSNotifications of Major Interests in Shares
3rd Oct 20137:00 amRNSConfirmation of Quarterly Interim Dividend
19th Sep 20131:33 pmRNSResults of AGM
11th Sep 20137:00 amRNSAcquisition of 32 medical centres for £62.5m
20th Aug 20134:35 pmRNSHolding(s) in Company
16th Aug 20137:00 amRNSAppointment of Joint Corporate Broker
12th Aug 20137:00 amRNSInterim Management Statement
24th Jul 201310:25 amRNSAnnual Information Update
22nd Jul 20134:04 pmRNSAnnual Report 2013
17th Jun 201310:05 amRNSConfirmation of Quarterly Interim Dividend
29th May 201311:42 amRNSForm 8.5 (EPT/NON-RI)
29th May 201310:54 amRNSForm 8.5 (EPT/NON-RI)
29th May 20139:46 amRNSForm 8.5 (EPT/NON-RI)
29th May 20139:38 amRNSForm 8.5 (EPT/RI)
28th May 20135:15 pmRNSOffer Update
28th May 20131:51 pmRNSForm 8.3 - Assura Group Ltd
28th May 201312:27 pmRNSRejection of MedicX Proposal
28th May 201312:26 pmRNSUnaudited Preliminary Results to 31 March 2013

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.